Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-013378
Date:2021-02-21
Issuer: HORIZON THERAPEUTICS PUBLIC LTD CO (HZNP)
Original Submission Date:

Reporting Person:

DESJARDIN MICHAEL A.
C/O HORIZON THERAPEUTICS PLC,
CONNAUGHT HOUSE 1ST FL, 1 BURLINGTON RD DUBLIN, L2 4

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2021-02-21 M 2,182 a $0.00 104,372 direct
ORDINARY SHARES 2021-02-21 F 1,082 d $88.87 103,290 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-02-21 deemed execution date M 2,182 (d) ordinary shares 2,182 $0.00 0 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.
f2 on february 21, 2017, the reporting person was granted 8,726 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Elevate your investments